−7.52 B KRW
4.88 B KRW
4.74 M
About NEXTBIOMEDICAL CO., LTD.
Sector
CEO
Don-Haeng Lee
Headquarters
Inchon
Website
Founded
2014
ISIN
KR7389650003
FIGI
BBG01N8PJLB5
Nextbiomedical Co. Ltd. engages in the development of therapeutics based on polymer and drug delivery system technologies. Its products include Nexpowder: Hemostatic Systems for Endoscopy, Nexsphere: Resorbable Gelatin Microspheres for Tailored Embolization, Nexsphere-F: Fast-Resorbable Gelatin Microspheres for Musculoskeletal Embolization and NexGel: Resorbable Gelatin Microparticle for Embolization. The company was founded on August 1, 2014 and is headquartered in Incheon, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 389650 is 37,250 KRW — it has decreased by −4.97% in the past 24 hours. Watch NEXTBIOMEDICAL CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange NEXTBIOMEDICAL CO., LTD. stocks are traded under the ticker 389650.
389650 stock has fallen by −9.15% compared to the previous week, the month change is a 17.32% rise, over the last year NEXTBIOMEDICAL CO., LTD. has showed a 37.96% increase.
389650 reached its all-time high on Nov 29, 2024 with the price of 48,800 KRW, and its all-time low was 21,400 KRW and was reached on Aug 21, 2024. View more price dynamics on 389650 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
389650 stock is 6.33% volatile and has beta coefficient of 3.32. Track NEXTBIOMEDICAL CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is NEXTBIOMEDICAL CO., LTD. there?
Yes, you can track NEXTBIOMEDICAL CO., LTD. financials in yearly and quarterly reports right on TradingView.
389650 net income for the last quarter is −1.34 B KRW, while the quarter before that showed 4.41 B KRW of net income which accounts for −130.33% change. Track more NEXTBIOMEDICAL CO., LTD. financial stats to get the full picture.
No, 389650 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 72.00 employees. See our rating of the largest employees — is NEXTBIOMEDICAL CO., LTD. on this list?
Like other stocks, 389650 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEXTBIOMEDICAL CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.